Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. [electronic resource]
Producer: 20070220Description: 2078-81 p. digitalISSN:- 0885-3185
- Aged
- Aged, 80 and over
- Antipsychotic Agents -- therapeutic use
- Aripiprazole
- Dose-Response Relationship, Drug
- Drug Tolerance
- Drug-Related Side Effects and Adverse Reactions
- Female
- Humans
- Male
- Middle Aged
- Parkinson Disease -- complications
- Pilot Projects
- Piperazines -- therapeutic use
- Psychiatric Status Rating Scales
- Psychotic Disorders -- drug therapy
- Quinolones -- therapeutic use
- Severity of Illness Index
- Time Factors
No physical items for this record
Publication Type: Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.